PharmaCyte Biotech Inc (PMCB)

[bonrox]

Revenue will make the stock go up, however, that is hardly the only thing that will make very large gains. Let's list them:

1. Starting 2B trials will bump it up and should hold barring bad news.

2. Starting TD2 trials will bump it up and probably won't hold it until results are totally in.

3. EU and Australia orphan will bump it up and drop again.

4. FDA Fast-track will skyrocket the price and will hold barring bad news from the field.

All of these will affect the pps and will not generate revenue. There are also up-listing to NASDAQ or a buyout which will up the pps.

I am long here for all of these reasons. This is not a pump and dump and this company really does want to make it. If they do, we will profit, and if they fail, we will lose.

They are not just trying to play us like many penny stocks do.